GlassScriptPhysician profile
Kyle R Libbey
NPI 1033620943
$3,496.84
in general payments reported to CMS, 2019-2025
34 companies · $1,063 in 2025
The $1,063 reported for 2025 was more than what 92% of Adolescent Medicine (Family Medicine) providers received nationally (typical 2025 total: $135).
See the full distribution for Adolescent Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $20.52 · 2023: $1,084 · 2024: $1,330 · 2025: $1,063.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,476.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,476.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $614.75 | 2023-2025 | |
| Pfizer INC. | $534.34 | 2023-2025 | |
| Novo Nordisk INC | $428.08 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Glaxosmithkline, LLC. | $237.27 | 2023-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $228.24 | 2022-2025 | Mounjaro, Trulicity, Zepbound |
| Amgen INC. | $138.18 | 2024-2025 | Repatha, Krystexxa, Repatha |
| Astellas Pharma US INC | $137.70 | 2023-2025 | Veozah, Myrbetriq |
| Medtronic, INC. | $115.42 | 2023-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Boston Scientific Corporation | $109.78 | 2023-2024 | Watchman Flx, Wavewriter Alpha Prime 16, Spectra Wavewriter |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $105.37 | 2025 | Caplyta |
| Exact Sciences Corporation | $74.55 | 2023-2024 | Cologuard Collection Kit |
| Xeris Pharmaceuticals, INC. | $73.30 | 2023-2024 | Keveyis, Gvoke Hypopen |
| Astrazeneca Pharmaceuticals LP | $62.65 | 2024-2025 | Breztri, Airsupra, Farxiga |
| Sumitomo Pharma America, INC. | $54.41 | 2024-2025 | Gemtesa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.57 | 2023-2024 | Jardiance |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $46.21 | 2025 | Sapien 3 Ultra Resilia |
| Corcept Therapeutics | $44.22 | 2024-2025 | Korlym |
| Bayer Healthcare Pharmaceuticals INC. | $44.03 | 2023-2025 | |
| Otsuka America Pharmaceutical, INC. | $43.13 | 2024-2025 | Rexulti |
| Abiomed | $40.33 | 2025 | |
| Biocryst US Sales Co., LLC | $33.34 | 2024 | Orladeyo |
| Mayne Pharma Commercial LLC | $30.11 | 2024 | |
| Dexcom, INC. | $28.33 | 2025 | Dexcom G6 Transmitter |
| Daiichi Sankyo INC. | $26.22 | 2025 | Injectafer |
| Irhythm Technologies, INC. | $25.80 | 2024 | Zio Xt Patch, Zio Monitor |
| Stryker Corporation | $25.77 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Viatris Specialty LLC | $23.04 | 2025 | Yupelri |
| Inari Medical, INC. | $22.66 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Idorsia Pharmaceuticals US INC | $22.49 | 2023 | Quviviq |
| Merck Sharp & Dohme LLC | $19.23 | 2025 | Capvaxive, Gardasil 9 |
| Esperion Therapeutics, INC. | $15.77 | 2025 | Nexletol |
| Inspire Medical Systems, INC. | $14.24 | 2025 | Inspire |
| Axsome Therapeutics, INC. | $13.14 | 2024 | Auvelity |
| Sonex Health, INC. | $11.17 | 2025 | Sx-One Microknife |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Libbey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.